.png)
About the Company:
Robotimize Group which is a global leader in neurorehabilitation robotics which is formation of its Scientific Advisory Board (SAB). The development unites a cadre of internationally recognised experts combined their knowledge and visionary insights to instrumental in steering the company’s research, development, and global strategy.
The establishment of the SAB reinforces Robotimize Group’s commitment to revolutionising patient care through innovative, evidencebased robotic solutions in the field of neurorehabilitation.
Robotimize Group’s Scientific Advisory Board are carefully curated to include luminaries from academia, clinical practice, and industry. These experts bring decades of experience and cutting-edge research in robotics, neural engineering, sensorimotor systems, and clinical rehabilitation.
Their collective expertise is set to accelerate Robotimize’s mission of transforming neurorehabilitation, enabling the company to address unmet clinical needs through breakthrough technological advancements.
Name
Robotimize Pte Ltd
ACRA
202237458N
Website
Phone
91129816
Year
Founded
2022
Address
11 River Valley Close #26-04 Starlight Suites
"Engineering Hope, Optimizing Healith The Future of Accessible Healthcare Technology"
The Director
Kerry Guo
About the
Director:
Kerry Guo is a distinguished leader in global healthcare management, with over 20 years of expertise in the industry. She spent nearly a decade in senior roles at GlaxoSmithKline (GSK) in the UK and Novartis in Switzerland, where she led strategic projects for Greater China, driving multiple innovative initiatives across the healthcare landscape.
In 2014, Kerry founded KWellness Group, which quickly rose to prominence as a leading provider of premium health management services to Fortune 500 companies, publicly listed corporations, private banking clients, and family offices, setting new benchmarks in global health management. She founded ROBOTIMIZE Group in 2022 too.
Building on her success in the healthcare industry, Kerry expanded into functional medicine, medical devices, and neurorehabilitation robotics. In 2016, she made a strategic acquisition that marked her formal entry into the rehabilitation medicine sector, introducing cutting-edge international medical technologies and building an extensive distribution network across Southeast Asia and China.
Under her leadership, her team earned numerous accolades, including the Singapore Government’s Entrepreneurial Spirit Award in 2022, a feature on China Central Television in 2023, and the prestigious Asia-Pacific Outstanding Brand Award in 2024.
Kerry’s forward-thinking vision led her to found ROBOTIMIZE Group with world-renowned rehabilitation experts, introducing state-of-the-art medical technologies to the Southeast Asian market, spanning anti-aging, rehabilitation, medical care, and sports health.
Additionally, she joined forces with other successful entrepreneurs to establish the Asia Health Fund, focused on investing in innovative healthcare projects, creating a comprehensive health ecosystem, and offering philanthropic support to communities in need.
In 2024, Kerry launched the flagship Asia LONGEVITY CENTER in Singapore, combining her decades of experience in health management with the latest advancements in medical devices to pioneer cellular repair and anti-aging solutions, fostering healthier lifestyles and contributing to societal well-being.
